In Europe, the administration of a non-invasive CA-125 blood test is considered the “go to” step, once ovarian cancer is suspected. In the U.S., there is resistance to utilizing this step, which we believe contributes unnecessarily to late-stage diagnosis and premature death of ovarian cancer victims.
In order to thoroughly understand the U.S. insurance industry’s and medical community’s perception of using CA-125 blood testing as a non-invasive precautionary step in assessing the possible presence of ovarian cancer in a patient with a history of the disease in their family or who is experiencing a number of the signs and symptoms of early ovarian cancer’s presence, we are hosting both a series of confidential Focus Groups and establishing a permanent “Feedback Panel” of medical professionals.
To qualify for Focus Group and/or Feedback Panel participation, we are seeking medical professionals who have had direct experience in treating patients diagnosed with ovarian cancer within the last five years.
We are seeking licensed medical doctors and nurse practitioners with such experience.
Focus Groups will be held remotely (by Zoom or Teams), and each participant’s identity will remain confidential during the Focus Group event, to assure honest feedback. Focus Groups will be scheduled to take place in the evenings (between 5:30 – 7:30 pm, EDT) and will involve practitioners from across the United States, Canada and Western Europe, and will last no more than 90 minutes, facilitated by a representative from the Bridget Nesko Memorial Scholarship Foundation, Inc. and an independent focus group company not affiliated with the Foundation.
Participants will receive a small cash honorarium and will receive tax credit for their in-kind contribution of time donated for their participation at their standard billing rate for such time.
For consideration, please complete the following questionnaire and our Focus Group Team Leader will contact you within 48 hours to discuss additional particulars and review available times for your participation.
As a medical professional, please be assured that you are contributing towards the probability of saving or extending lives, regardless of the Pilot Program’s outcome.
Please contact Kevin Nesko, Director and Trustee for the Bridget Nesko Memorial Scholarship Foundation, Inc. (which will be underwriting this initiative) at (856) 595 2184, or by email, at [email protected].